Diabetics with fatty livers could benefit from diet rich in soy protein

According to a group of researchers from Mexico they have discovered that a diet rich in soy protein may alleviate fatty liver, a disease which often accompanies diabetes.

The high levels of insulin and insulin-resistance that accompany diabetes, are often associated with fatty liver or hepatic steatosis, an untreatable condition that can lead to chronic liver disease and death.

The condition causes large lipid-filled compartments to accumulate in the cells of the liver due to an increase in the production of fatty acids, with the result that the liver becomes enlarged.

Dr. Nimbe Torres, of the Instituto Nacional de Ciencias Medicas y Nutricion in Mexico, used prior research that had indicated that eating soy protein reduces lipid production and prevents hyperinsulinemia (the loss of effectiveness of insulin),as a basis for his work.

Dr. Torres investigated the effects of a diet high in soy protein on the development of fatty liver associated with diabetes.

She fed diabetic rats that develop hyperinsulinemia and hepatic steatosis, a diet of soy protein for 160 days, and found that the consumption of soy protein prevented the accumulation of triglycerides and cholesterol in the liver, despite the development of obesity and hyperinsulinemia in the rats.

She says that feeding rats a soy-rich diet, reduced the amount of fatty acid in their liver by not only reducing lipid production, but also by increasing its breakdown.

Although further research is needed, Dr. Torres believes that consuming soy protein could very well reduce insulin resistance, renal damage, and fatty liver, and improve quality of life.

The details of their findings appear in the September issue of the Journal of Lipid Research, an American Society for Biochemistry and Molecular Biology journal.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Nomic® and Parker Institute for Cancer Immunotherapy (PICI) launch large-scale protein profiling to investigate immunotherapy responses in RADIOHEAD study